Find therapies in clinical trials near you – page 489

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Fed‑State Bioequivalence Study of Nitrofurantoin 100 mg Prolonged‑Release Capsules in Healthy Volunteers

Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy

A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy

Bioequivalence study of fluticasone propionate and salmeterol xinafoate inhalation powder in healthy volunteers for asthma treatment

Bioequivalence study of fluticasone propionate and salmeterol xinafoate inhalation powder in healthy volunteers for asthma treatment

A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

Bioavailability Study of Rosuvastatin and Ezetimibe with Bempedoic Acid in Healthy Male and Female Volunteers

Comparison of Bioavailability of Ruxolitinib Phosphate 20 mg Tablet vs Ruxolitinib 20 mg Tablet in Healthy Volunteers

Bioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms

Bioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms

Study of BI 1810631 oral bioavailability in healthy men under fed vs fasted conditions

Study of BI 1810631 oral bioavailability in healthy men under fed vs fasted conditions

Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study